Listar por autor "Carra, Adriana"

Ordenar por:Orden:Resultados:

  • Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America 
    Steinberg, Judith; Fragoso, Yara D.; Duran Quiroz, Juan Carlos; Garcia, Juan Raul; Guerra, Caroline; Rodriguez, Virginia; Carcamo Rodriguez, Claudia; Ciampi, Ethel; Correa-Diaz, Edgar; Macias, Miguel; Novarro, Nelson; Vizcarra-Escobar, Darwin; Oehninger Gatti, Carlos; Orozco, Geraldine; Carra, Adriana (Springer, 2019)
    The use of biosimilar drugs for multiple sclerosis (MS) has become widespread in Latin America, with the goal of reducing costs of treatments, promoting the sustainability of healthcare systems, and improving patient ...
  • Research priorities in multiple sclerosis in Latin America: A multi-stakeholder call to action to improve patients care: Research priorities in MS in LATAM 
    Rojas, Juan I.; Carnero-Contentti, Edgar; Abad, Patricio; Aguayo, Adriana; Alonso, Ricardo; Bauer, Johana; Becker, Jefferson; Bustos, Andrea K.; Carcamo, Claudia A.; Carra, Adriana; Correa-Díaz, Edgard P.; Correale, Jorge; Cristiano, Edgardo; Díaz, Alejandro J.; Fernández-Liguori, Nora; Flores, Jose; Fruns, Manuel; Garcea, Orlando; Giachello, Susana M.; Godoy, Melisa D.; Gracia, Fernando; Hamuy, Victor F.; Henestroza, Paula R.; Navarra, Javier A.; Navas, Carlos; Patrucco, Liliana; Pérez-Bruno, Magdalena; Prato, Andrea S.; Rivera, Víctor M.; Rosa-Martínez, Alma R.; Vanotti, Sandra; Vazquez, Macarena; Vizcarra-Escobar, Darwin; Ysrraelit, Maria C.; Alonso-Serena, Marina (Elsevier, 2021)
    As human and economic resources are limited, especially in Latin America (LATAM), it is important to identify research priorities to improve multiple sclerosis (MS) patients care in the region. The objective was to generate ...

Buscar en el Repositorio

Listar

Panel de Control